Triple therapy versus dual or monotherapy with long-acting bronchodilators for chronic obstructive pulmonary disease. A systematic review and meta-analysis

MJ Mammen, DR Lloyd, S Kumar… - Annals of the …, 2020 - atsjournals.org
Rationale: There is uncertainty on the use of using triple therapy (inhaled
corticosteroids/long-acting β-agonist/long-acting muscarinic antagonist) inhaler therapy for …

[引用][C] Triple Therapy versus Dual or Monotherapy with Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta …

MJ Mammen, DR Lloyd, S Kumar, AS Ahmed… - Annals of the American …, 2020 - cir.nii.ac.jp
Triple Therapy versus Dual or Monotherapy with Long-Acting Bronchodilators for Chronic
Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis | CiNii Research …

Triple Therapy versus Dual or Monotherapy with Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis

MJ Mammen, DR Lloyd, S Kumar… - Annals of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Rationale: There is uncertainty on the use of using triple therapy (inhaled
corticosteroids/long-acting β-agonist/long-acting muscarinic antagonist) inhaler therapy for …

[PDF][PDF] SYSTEMATIC REVIEWS

MJ Mammen, DR Lloyd, S Kumar… - Ann Am Thorac …, 2020 - researchgate.net
Rationale: There is uncertainty on the use of using triple therapy (inhaled
corticosteroids/long-acting b-agonist/long-acting muscarinic antagonist) inhaler therapy for …

Triple Therapy versus Dual or Monotherapy with Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis.

MJ Mammen, DR Lloyd, S Kumar… - Annals of the …, 2020 - europepmc.org
Rationale: There is uncertainty on the use of using triple therapy (inhaled
corticosteroids/long-acting β-agonist/long-acting muscarinic antagonist) inhaler therapy for …